Status:

COMPLETED

A Clinical Study to Evaluate the Tolerability of a Topical Antibiotic and Retinoid Used in a Combined Regimen With a BPO Wash

Lead Sponsor:

Stiefel, a GSK Company

Collaborating Sponsors:

GlaxoSmithKline

Conditions:

Acne Vulgaris

Eligibility:

All Genders

12-45 years

Phase:

PHASE3

Brief Summary

The purpose of this study is to evaluate the tolerability of a combined regimen of a topical antibiotic and retinoid and a benzoyl peroxide wash.

Eligibility Criteria

Inclusion

  • Subjects with mild to moderate facial acne vulgaris, with no history of known or suspected hypersensitivity or previous allergic reaction to any of the ingredients of the study products (eg, topical antibiotics, retinoids or benzoyl peroxide), capable of understanding and willing to provide signed and dated written voluntary informed consent and able to complete the study and to comply with study instructions.
  • Female subjects of childbearing potential must have a negative urine pregnancy test result at baseline and practice a reliable method of contraception throughout the study.

Exclusion

  • Use of topical antibiotics on the face within the past 2 weeks or use of systemic antibiotics within the past 4 weeks.

Key Trial Info

Start Date :

April 1 2009

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 5 2009

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT00891982

Start Date

April 1 2009

End Date

June 5 2009

Last Update

May 24 2017

Active Locations (5)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (5 locations)

1

Dermatology Associates Research

Coral Gables, Florida, United States, 33134

2

Grekin Skin Institute

Warren, Michigan, United States, 48088

3

Dermatology Consulting Services

High Point, North Carolina, United States, 27262

4

The Skin Wellness Center, PC

Knoxville, Tennessee, United States, 37922